KR100894439B1 - 아토피성 피부염의 예방 효과를 가지는 화장료 조성물 및 그 제조 방법 - Google Patents
아토피성 피부염의 예방 효과를 가지는 화장료 조성물 및 그 제조 방법 Download PDFInfo
- Publication number
- KR100894439B1 KR100894439B1 KR1020080105169A KR20080105169A KR100894439B1 KR 100894439 B1 KR100894439 B1 KR 100894439B1 KR 1020080105169 A KR1020080105169 A KR 1020080105169A KR 20080105169 A KR20080105169 A KR 20080105169A KR 100894439 B1 KR100894439 B1 KR 100894439B1
- Authority
- KR
- South Korea
- Prior art keywords
- atopic dermatitis
- weight
- composition
- cosmetic composition
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 201000008937 atopic dermatitis Diseases 0.000 title claims abstract description 54
- 206010012438 Dermatitis atopic Diseases 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 239000002537 cosmetic Substances 0.000 title claims abstract description 22
- 230000000069 prophylactic effect Effects 0.000 title claims description 14
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 6
- 230000002829 reductive effect Effects 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims abstract description 3
- 239000006210 lotion Substances 0.000 claims description 22
- 239000006071 cream Substances 0.000 claims description 19
- 235000019568 aromas Nutrition 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000003449 preventive effect Effects 0.000 claims 3
- 208000003251 Pruritus Diseases 0.000 abstract description 11
- 230000007803 itching Effects 0.000 abstract description 8
- 235000016709 nutrition Nutrition 0.000 abstract description 7
- 230000035764 nutrition Effects 0.000 abstract description 7
- 241000196324 Embryophyta Species 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 5
- 244000141218 Alpinia officinarum Species 0.000 abstract description 3
- 241000271307 Aquilaria malaccensis Species 0.000 abstract description 3
- 240000005528 Arctium lappa Species 0.000 abstract description 3
- 235000003130 Arctium lappa Nutrition 0.000 abstract description 3
- 241000202722 Bupleurum falcatum Species 0.000 abstract description 3
- 240000003803 Torilis japonica Species 0.000 abstract description 3
- 230000003020 moisturizing effect Effects 0.000 abstract description 3
- 206010039897 Sedation Diseases 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- 230000036280 sedation Effects 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 34
- 230000000694 effects Effects 0.000 description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 10
- 201000004624 Dermatitis Diseases 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 7
- 206010040880 Skin irritation Diseases 0.000 description 7
- 230000007794 irritation Effects 0.000 description 7
- 231100000475 skin irritation Toxicity 0.000 description 7
- 230000036556 skin irritation Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 229910000831 Steel Inorganic materials 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 208000017520 skin disease Diseases 0.000 description 5
- 239000010959 steel Substances 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 231100000957 no side effect Toxicity 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 206010012434 Dermatitis allergic Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000024780 Urticaria Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 125000003158 alcohol group Chemical group 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 230000037336 dry skin Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000003630 histaminocyte Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- BBMFSGOFUHEVNP-UHFFFAOYSA-N 4-hydroxy-2-methylbenzoic acid Chemical compound CC1=CC(O)=CC=C1C(O)=O BBMFSGOFUHEVNP-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 241001116389 Aloe Species 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 102000007478 beta-N-Acetylhexosaminidases Human genes 0.000 description 2
- 108010085377 beta-N-Acetylhexosaminidases Proteins 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- OMRLTNCLYHKQCK-DHGKCCLASA-N 4-nitrophenyl N-acetyl-beta-D-glucosaminide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([N+]([O-])=O)C=C1 OMRLTNCLYHKQCK-DHGKCCLASA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 208000028185 Angioedema Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000218671 Ephedra Species 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000007984 Female Infertility Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010021928 Infertility female Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- QMAYBMKBYCGXDH-SOUVJXGZSA-N alpha-Cadinene Natural products C1CC(C)=C[C@@H]2[C@H](C(C)C)CC=C(C)[C@@H]21 QMAYBMKBYCGXDH-SOUVJXGZSA-N 0.000 description 1
- QMAYBMKBYCGXDH-UHFFFAOYSA-N alpha-amorphene Natural products C1CC(C)=CC2C(C(C)C)CC=C(C)C21 QMAYBMKBYCGXDH-UHFFFAOYSA-N 0.000 description 1
- QMAYBMKBYCGXDH-KKUMJFAQSA-N alpha-cadinene Chemical compound C1CC(C)=C[C@H]2[C@H](C(C)C)CC=C(C)[C@@H]21 QMAYBMKBYCGXDH-KKUMJFAQSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003716 antitrichomonal agent Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 108010067755 dinitrophenyl-bovine serum albumin Proteins 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000009390 immune abnormality Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
화장료는 화장수, 영양로션, 영양크림, 마사지용 로션 크림, 세안용 화장품, 팩, 바디용 제품 및 베이비용 제품 중에서 선택된 제형을 갖는다.
또한 본 발명에 따른 아토피성 피부염의 예방 효과를 가지는 조성물은 통상적인 사용방법에 따라 사용될 수 있으며, 사용자의 피부 상태 또는 취향에 따라 그 사용횟수를 달리할 수 있다.
순번 | 종류 | 추출전 무게(g) | 추출후 무게(g) |
1 | 사상자 | 15 | |
2 | 침향 | 20 | |
3 | 고량강 | 23 | |
4 | 우방자 | 25 | |
5 | 시호 | 17 | |
합계 | 100 | 2.5 |
분류 | 원료명 | 무게(중량%) |
알콜부분 | 에탄올 | 7 |
카모마일 오일 | 0.02 | |
메틸파라히드록시벤조익산 | 0.1 | |
Tween-20 | 0.05 | |
PEG-40 하이드로게네이티드 캐스터 오일 | 0.1 | |
정제수부분 | 정제수 | 89.24 |
글리세린 | 0.1 | |
1,3-부틸렌글리콜 | 0.2 | |
β-Glucan | 0.1 | |
히아루론산 | 0.5 | |
알란토인 | 0.05 | |
구연산 | 0.01 | |
구연산소다 | 0.03 | |
생약제부분 | 천연 혼합 추출물(실시예 1) | 2.5 |
합계 | 100 |
분류 | 원료명 | 무게(중량%) |
알콜부분 | 스테아린산 | 2.1 |
세탄올 | 1.3 | |
유동파라핀 | 7.0 | |
스쿠알렌 | 0.5 | |
이소프로필 미리스테이트 | 1.0 | |
글리세릴 모노스테아레이트 | 0.5 | |
Arlacel-60 | 0.85 | |
Tween-20 | 0.1 | |
이소스테아릴-이소스테아레이트 | 0.5 | |
프로필파라벤 | 0.1 | |
실리콘 오일 200F/100CS | 0.1 | |
정제수부분 | 정제수 | 69.65 |
트리에탄올아민 | 0.7 | |
프로필렌글리콜 | 7.0 | |
글리세린 | 3.0 | |
메틸파라히드록시벤조익산 | 0.1 | |
생약제 | 천연 혼합 추출물(실시예 1) | 5.5 |
합계 | 100 |
시료 | 매우 양호 | 양호 | 변화없슴 | 나쁨 |
스킨로션 | 2 | 7 | 6 | 5 |
밀크 영양크림 | 2 | 8 | 6 | 4 |
시료 | 매우 양호 | 양호 | 변화없슴 | 나쁨 |
스킨로션 | 2 | 7 | 6 | 5 |
밀크 영양크림 | 2 | 8 | 6 | 4 |
농도(ppm) | 억제율(%) | |
천연혼합추출물 | quercetin | |
5 | 8.0 | 18.6 |
10 | 13.4 | 32.1 |
20 | 42.3 | 46.8 |
50 | 53.1 |
농도(ppm) | 억제율(%) | |
천연혼합추출물 | quercetin | |
10 | 4.9 | 23.2 |
20 | 13.2 | 48.9 |
50 | 28.5 | 62.4 |
100 | 40.8 |
Claims (5)
- 주요 천연 성분으로서 사상자, 침향, 고량강, 우방자, 시호로 구성되어진 혼합 추출물을 함유하는 것을 특징으로 하는 아토피성 피부염의 예방 효과를 가지는 화장료 조성물.
- 제 1항에 있어서,각 천연 성분의 조성은 각각의 건조중량을 기준으로 하여 사상자 1 ~ 30 중량%, 침향 1 ~ 30 중량%, 고량강 1 ~ 30 중량%, 우방자 1 ~ 30 중량%, 시호 1 ~ 30 중량% 로 구성되어지는 것을 특징으로 하는 아토피성 피부염의 예방 효과를 가지는 화장료 조성물.
- 각 천연 성분의 조성은 각각의 건조중량을 기준으로 하여 사상자 1 ~ 30 중량%, 침향 1 ~ 30 중량%, 고량강 1 ~ 30 중량%, 우방자 1 ~ 30 중량%, 시호 1 ~ 30 중량% 의 배합비로 구성되어지며, 상기의 배합비로 혼합한 생약을 열수 추출하여 여과하고, 감압 농축하여 제조되는 조성물을 0.001 ~ 30 중량%로 화장료에 함유함을 특징으로 하는 아토피성 피부염의 예방 효과를 가지는 화장료 조성물을 제조하는 방법.
- 제 1항 또는 제2항에 있어서,상기 화장료는 화장수, 영양로션, 영양크림, 마사지용 로션 크림, 세안용 화장품, 팩, 바디용 제품 및 베이비용 제품 중에서 선택된 제형을 갖는 것을 특징으로 하는 아토피성 피부염의 예방 효과를 가지는 화장료 조성물.
- 제 3항에 있어서,상기 화장료는 화장수, 영양로션, 영양크림, 마사지용 로션 크림, 세안용 화장품, 팩, 바디용 제품 및 베이비용 제품 중에서 선택된 제형을 갖는 것을 특징으로 하는 아토피성 피부염의 예방 효과를 가지는 화장료 조성물을 제조하는 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080105169A KR100894439B1 (ko) | 2008-10-27 | 2008-10-27 | 아토피성 피부염의 예방 효과를 가지는 화장료 조성물 및 그 제조 방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080105169A KR100894439B1 (ko) | 2008-10-27 | 2008-10-27 | 아토피성 피부염의 예방 효과를 가지는 화장료 조성물 및 그 제조 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100894439B1 true KR100894439B1 (ko) | 2009-04-22 |
Family
ID=40758026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080105169A Active KR100894439B1 (ko) | 2008-10-27 | 2008-10-27 | 아토피성 피부염의 예방 효과를 가지는 화장료 조성물 및 그 제조 방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100894439B1 (ko) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104288026A (zh) * | 2014-09-27 | 2015-01-21 | 张乔木 | 一种洗手液及其制备方法 |
KR20180026822A (ko) * | 2016-09-05 | 2018-03-14 | 백희순 | 에센스 오일 화장료 제조방법 |
KR20180064202A (ko) * | 2016-12-05 | 2018-06-14 | 주식회사 파마진 | 사상자 추출물 및 카퍼트리펩타이드-1 혼합물을 유효성분으로 함유하는 아토피 피부염의 예방, 개선 또는 치료용 조성물 |
KR20220165887A (ko) * | 2021-06-08 | 2022-12-16 | 김현정 | 아토피 피부염의 진정을 위한 원통형 습윤밴드 및 이의 제조방법 |
WO2023204363A1 (ko) * | 2022-04-20 | 2023-10-26 | 한국 한의학 연구원 | 고량강 추출물을 유효성분으로 포함하는 아토피 피부염의 예방, 개선 또는 치료용 조성물 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030092519A (ko) * | 2002-05-30 | 2003-12-06 | 주식회사 리젠 바이오텍 | 알레르기성 피부질환의 개선 또는 예방용 조성물 |
KR20060073708A (ko) * | 2004-11-17 | 2006-06-29 | 최양원 | 아토피성 피부질환 한방치료제의 제조방법 |
KR20060092373A (ko) * | 2005-02-17 | 2006-08-23 | (주)네오팜 | 소아 아토피 피부염의 예방 및 개선용 생약 조성물 |
-
2008
- 2008-10-27 KR KR1020080105169A patent/KR100894439B1/ko active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030092519A (ko) * | 2002-05-30 | 2003-12-06 | 주식회사 리젠 바이오텍 | 알레르기성 피부질환의 개선 또는 예방용 조성물 |
KR20060073708A (ko) * | 2004-11-17 | 2006-06-29 | 최양원 | 아토피성 피부질환 한방치료제의 제조방법 |
KR20060092373A (ko) * | 2005-02-17 | 2006-08-23 | (주)네오팜 | 소아 아토피 피부염의 예방 및 개선용 생약 조성물 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104288026A (zh) * | 2014-09-27 | 2015-01-21 | 张乔木 | 一种洗手液及其制备方法 |
CN104288026B (zh) * | 2014-09-27 | 2016-12-28 | 青岛申达众创技术服务有限公司 | 一种洗手液及其制备方法 |
KR20180026822A (ko) * | 2016-09-05 | 2018-03-14 | 백희순 | 에센스 오일 화장료 제조방법 |
KR101870030B1 (ko) * | 2016-09-05 | 2018-07-20 | 백희순 | 에센스 오일 화장료 제조방법 |
KR20180064202A (ko) * | 2016-12-05 | 2018-06-14 | 주식회사 파마진 | 사상자 추출물 및 카퍼트리펩타이드-1 혼합물을 유효성분으로 함유하는 아토피 피부염의 예방, 개선 또는 치료용 조성물 |
KR101964249B1 (ko) | 2016-12-05 | 2019-04-01 | 주식회사 파마진 | 사상자 추출물 및 카퍼트리펩타이드-1 혼합물을 유효성분으로 함유하는 아토피 피부염의 예방, 개선 또는 치료용 조성물 |
KR20220165887A (ko) * | 2021-06-08 | 2022-12-16 | 김현정 | 아토피 피부염의 진정을 위한 원통형 습윤밴드 및 이의 제조방법 |
KR102507262B1 (ko) | 2021-06-08 | 2023-03-09 | 김현정 | 아토피 피부염의 진정을 위한 원통형 습윤밴드 및 이의 제조방법 |
WO2023204363A1 (ko) * | 2022-04-20 | 2023-10-26 | 한국 한의학 연구원 | 고량강 추출물을 유효성분으로 포함하는 아토피 피부염의 예방, 개선 또는 치료용 조성물 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008140200A1 (en) | External compositions for the skin | |
US20130108599A1 (en) | Herbal Vaginal Compositions | |
CN104434740B (zh) | 一种中药祛痘凝胶剂及其制备方法 | |
CN109394959B (zh) | 一种具有修复皮肤角质层功效的中药组合物及其水提物和发酵物及应用 | |
CN113521164B (zh) | 一种具有抑菌作用的藏药组合物及其制备方法和应用 | |
CN105030621A (zh) | 一种保湿祛痘爽肤水及其制备方法 | |
KR100875577B1 (ko) | 아토피 피부염 예방 및 개선용 크림 제조방법 | |
KR102026535B1 (ko) | 생약 추출 혼합물을 포함하는 화장료 조성물 | |
KR100894439B1 (ko) | 아토피성 피부염의 예방 효과를 가지는 화장료 조성물 및 그 제조 방법 | |
CN105106655A (zh) | 一种修复性烧伤烫伤膏及其制备方法 | |
CN103182045A (zh) | 一种治疗手足癣的药物及其制备方法 | |
KR101047612B1 (ko) | 여드름 및 여드름양 발진 완화용 또는 치료용 화장료 조성물 | |
CN107496792A (zh) | 一种消炎抗菌治疗灰指甲的凝胶剂及其制备方法 | |
CN115518127B (zh) | 一种抑菌抗炎消肿止痒乳膏及其制备方法 | |
CN114306410B (zh) | 一种紫草膏及其制备方法与应用 | |
KR20200093154A (ko) | 한방 여성청결제 | |
CN112870269B (zh) | 具有抗菌、杀菌、治疗湿疹功效的天然植物制剂组合物 | |
KR20060074038A (ko) | 아토피성 피부염의 예방 효과를 가지는 조성물 | |
CN108641833A (zh) | 一种消炎抗菌手工皂及其制备方法 | |
CN108553543A (zh) | 一种紫草膏及其制备方法 | |
KR20100093151A (ko) | 아토피성 피부염의 예방 효과를 가지는 조성물 | |
KR100644086B1 (ko) | 피부자극이 없는 한방입욕제의 제조방법 | |
CN105343386A (zh) | 一种中药止痒洗发液及其制备方法 | |
CN115089675B (zh) | 一种治疗股藓的药物及其制备方法 | |
KR102420354B1 (ko) | 순환 활성 로션 조성물 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20081027 |
|
PA0201 | Request for examination | ||
A302 | Request for accelerated examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20081028 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20081027 Patent event code: PA03021R01I Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20090119 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20090414 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20090415 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20090415 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20120201 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20130129 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20130129 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140207 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20140207 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160510 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20160510 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170327 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20170327 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190415 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20190415 Start annual number: 11 End annual number: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20200414 Start annual number: 12 End annual number: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20210414 Start annual number: 13 End annual number: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20240407 Start annual number: 16 End annual number: 16 |
|
PR1001 | Payment of annual fee |
Payment date: 20250407 Start annual number: 17 End annual number: 17 |